Pharmacological Induction of Heme Oxygenase-1 by a Triterpenoid Protects Neurons Against Ischemic Injury
Author(s) -
Feng Zhang,
Suping Wang,
Meijuan Zhang,
Zhongfang Weng,
Peiying Li,
Yu Gan,
Lili Zhang,
Guodong Cao,
Yanqin Gao,
Rehana K. Leak,
Michael B. Sporn,
Jun Chen
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.647420
Subject(s) - medicine , heme oxygenase , heme , triterpenoid , pharmacology , ischemic injury , oxygenase , anesthesia , traditional medicine , ischemia , biochemistry , enzyme , chemistry
Heme oxygenase-1 (HO-1) is an inducible Phase 2 enzyme that degrades toxic heme; its role in cerebral ischemia is not fully understood. We hypothesize that chemically induced HO-1 upregulation with the novel triterpenoid CDDO-Im (2-cyano-3,12 dioxooleana-1,9 dien-28-oyl imidazoline), a robust inducer of Phase 2 genes, protects neurons against ischemic injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom